Skip to main navigation

A world of opportunity - Ernst & Young - Switzerland

HomeLibraryIssue Health Sciences
Library

Library – Your selection

Issue Health Sciences

The following items match your selection:
June 2007

  Historic Advances
The global biotech sector reported a record number of products in the pipeline and record inflows of risk capital in 2006. Switzerland, for its part, is the leading biotech location in the world in terms of size and number of inhabitants. And the future of the Swiss biotech industry remains rosy.  

Jürg Zürcher, Ernst & Young
Business Guide to Switzerland

April 2007

  A Prime Example of a Competitive Business Location
Switzerland is the location of choice for over 137 biotech companies and 81 biotech industry suppliers. In 2006 the Swiss biotech sector generated global revenue of over CHF 6 billion and employed over 14,000 people. In terms of size and number of inhabitants, Switzerland is the leading biotech location in the world.  

Jürg Zürcher, Ernst & Young
BIOforum Europe 4/2007

  Positive effects on the Swiss economy
Switzerland is the leading biotech location in the world in terms of size and number of inhabitants. Experiencing another successful year in 2006, the Swiss biotechnology industry nevertheless faced some unexpected market developments.  

Jürg Zürcher, Ernst & Young
L'Agefi, 04/07

Related content
Newsletters

 
Periodicals

Ernst & Young Online

Learn more
 
-->
-->
Back to top